Zimmer Biomet Gets 510(k) Clearance for Rosa Hip Replacement System

Zimmer Biomet has received the FDA’s 510(k) clearance for its Rosa Hip System for robotically assisted direct anterior total hip replacement.

Rosa Hip is intended to assist surgeons with positioning, using information collected by the device combined with data gathered using the myMobility remote care management platform on Apple Watch.

Rosa Hip is the fourth robotic system introduced by Warsaw, Ind.-based Zimmer Biomet. The company has also developed systems for total knee replacement, partial knee replacement, and for neurosurgical and spinal procedures.